These PAX5 alterations, together with a mutation in KRAS (p.G12D) and loss of CDKN2A, were identified in both the B-ALL and HS tissue, which supported the clonal relationship. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.